Dr. Brian Levy
Chief Executive Officer
Life Science
OCUNEXUS THERAPEUTICS, INC.
Singapore
Biography
Dr Levy has spent his career in ophthalmology and is a proven leader with a depth of experience in Drug and Device Development, Clinical Development and Medical Affairs. Dr. Levy has led 3 NDA's in Ophthalmic Pharmaceuticals, all approved and commercialized; Multiple PMA's and 510K’s for Cataract, Refractive and Vitreo-Retinal Surgical Devices, Intra Ocular Lenses and Contact Lenses in the US and Internationally including Europe and Asia. Dr. Levy was most recently Chief Medical Officer at Aerie Pharmaceuticals where he was a member of the Executive team that took the company public through a successful IPO. Prior to that he spent 15 years at Bausch & Lomb as Vice President R&D and then Chief Medical Officer for the Corporation. In these evolutionary roles he was responsible for Global Clinical and Product Development, Global Product Safety and Medical Affairs. Prior to joining Bausch & Lomb, Dr. Levy was Associate Professor in the Department of Ophthalmology at California Pacific Medical Center in San Francisco seeing patients in a clinical setting as part of a group faculty practice and carried out clinical research and teaching duties with ophthalmology residents and fellows. Prior to moving to Academic Ophthalmology Department he was in Clinical Practice in Toronto, took NEI courses in Epidemiology and Biostatistics in Vision Research and was a clinical investigator for numerous products in development and an advisor and consultant to the ophthalmic industry. Dr. Levy currently holds an appointment as Clinical Professor in the Department of Ophthalmology at the University of Rochester’s School of Medicine. He is a healthcare advisor to Spindletop Capital and serves on the boards of 3
Research Interest
Opthapalogy